The 10,000-step myth
The 10,000-step target has no scientific origin. It was coined by the Japanese pedometer manufacturer Yamasa in 1965 as a marketing slogan for their 'Manpo-kei' (10,000 steps meter) device. The number was chosen because the kanji character for 10,000 (万) resembles a walking figure — not because of any physiological threshold. For six decades, this marketing number has been repeated as health advice. The actual science tells a more nuanced story.
What the evidence actually shows
A 2022 meta-analysis in JAMA Internal Medicine pooled data from 15 studies covering 47,471 adults and found that all-cause mortality risk decreased progressively with step count up to approximately 8,000–10,000 steps per day, with the steepest decline occurring between 2,000 and 7,000 steps. Critically, the benefit was dose-dependent: every 1,000 additional steps per day was associated with a 10–15% reduction in all-cause mortality risk. The curve flattened above 8,000–10,000 steps — meaning there is little additional mortality benefit from walking 15,000 steps versus 10,000 steps.
A separate 2020 JAMA study of 4,840 adults from the NHANES cohort found that those taking 8,000 steps per day had a 51% lower risk of all-cause mortality compared to those taking 4,000 steps, and those taking 12,000 steps had a 65% lower risk. The step intensity (cadence) did not significantly modify the association after adjusting for total steps — suggesting that it is the volume of walking, not the pace, that drives the mortality benefit.
Mechanisms
- Cardiovascular: walking at moderate intensity improves endothelial function, reduces resting heart rate, and lowers systolic blood pressure by 3–5 mmHg — effects equivalent to low-dose antihypertensive medication.
- Metabolic: daily walking improves insulin sensitivity, reduces visceral adiposity, and lowers fasting glucose — all independent predictors of longevity.
- Musculoskeletal: weight-bearing walking preserves bone mineral density and maintains lower limb muscle mass, reducing fracture risk and fall-related mortality in older adults.
- Neurological: walking increases BDNF (brain-derived neurotrophic factor), which supports hippocampal neurogenesis and is associated with reduced dementia risk.
- Psychological: 20–30 minutes of walking reduces cortisol and activates the default mode network, with antidepressant effects comparable to low-dose SSRIs in mild-to-moderate depression.
The practical protocol
- Target 7,000–8,000 steps per day as your minimum. Use a phone or wearable to track — awareness alone increases step count by 2,000 steps/day on average.
- Break up prolonged sitting with 5-minute walking breaks every 60–90 minutes. Sitting for >8 hours per day is independently associated with elevated mortality even in people who exercise.
- Walk after meals: a 10–15 minute post-meal walk reduces postprandial glucose spikes by 20–30% and improves insulin sensitivity acutely.
- Add incline: walking uphill at even a 5% grade doubles the metabolic cost and provides a Zone 2 cardiovascular stimulus without requiring speed.
- Prioritise morning or outdoor walking: natural light exposure during morning walks entrains circadian rhythms and provides additional mood and metabolic benefits.
Dr. James Okafor, MD — Sports medicine physician and longevity researcher. Former research fellow at the Cooper Institute, which has tracked cardiorespiratory fitness and mortality in over 100,000 patients since 1970.
Reviewed by a second author before publication. Conflicts of interest disclosed in the masthead. Vitaei does not accept advertising or sponsored placements. Read our editorial policy →